Pirfenidone is a medication used to treat idiopathic pulmonary fibrosis ( chronic scarring lung disease characterized by a progressive and irreversible decline in lung function). Multiple companies around the world developed pirfenidone, and among them, the original patent holder Marnac, Inc. InterMune Inc., Shionogi Ltd., and GNI Group Ltd. Pirfenidone has been approved in different countries at different periods. Japan approved Pirfenidone medical use in 2008, 2010 in India, 2011 in Europe and China, 2012 in Canada, 2014 in the US and Mexico. Pirfenidone has many brand names, the most spread is Esbriet by Genentech, Inc in use in Europe, Canada, and the US, others are Pirespa by Shionogi, Pirfenex by Cipla, Estuary by GNI Group Ltd, KitosCell LP in Mexico. Pirfenidone suppliers market it in the form of oral capsules of 267 mg or oral tablets of 267 mg or 801 mg. In Mexico, Pirfenidone can be found under a topical form created for the treatment of abnormal wound healing processes. Warnings: Follow all Instructions on your medicine package and label. It is wise to tell your healthcare providers about all your medical allergies, illnesses, and all medicines you use. Before taking PIRFENIDONE: You should not use This medical drug if you are allergic to it This drug may also be used for purposes that may not have been listed in this medication guide. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified rosiglitazone manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.

The usage of this pharmaceutical substance: Read the Guide and, if available, the Patient Information Leaflet that will be provided by your pharmacist before you start taking PIRFENIDONE. If you have any questions related to this medical remedy, ask your pharmacist or doctor. To treat Idiopathic Pulmonary Fibrosis, an adult patient should take the initial dose of 267 mg oral capsule three a day from day one to day seven. From day eight today fourteen, the patient should take 534 mg of Pirfenidone three times a day. At the maintenance stage, the dose should not exceed 801 mg of Pirfenidone three times a day on day fifteen. During the treatment, Pirfenidone should be taken with food; it helps reduce nausea and dizziness. Taking Pirfenidone can cause some side effects, some of them include diarrhea, itching or skin rash, nausea, redness or other discoloration of the skin, severe sunburn, stomach discomfort, upset, or pain, vomiting. Take this pharmaceutical product by mouth with food as directed by your doctor, normally 3 times a day. Taking this medical drug with food may help minimize nausea and dizziness.

It is obtainable in generic and brand versions. It is not covered by most Medicare and insurance plans, but pharmacy coupons can help balance the price. In the US, under the brand name Esbriet, a 267 mg capsule and a 267 mg tablet cost about $38.12. An 801 mg oral tablet of Esbriet costs about $114.36. In the Pipelinepharma pharmaceutical marketplace, Pirfenidone is most available from the EU, Turkey, India, Argentina, and Guatemala. Prices may vary on the pharmacy you visit.

If you are looking to find manufacturers and suppliers of PIRFENIDONE, locate them quickly using Pipelinepharma's online marketplace. With this convenient B2B platform, you can order types of medications and quantities you require from companies that have passed our stringent vetting and quality control procedures. Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of PIRFENIDONE offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for this substance manufacturer and these substance suppliers that you are looking for. These also enable you to check the dossier status of this medicine, and the GMP approvals of the different variants of PIRFENIDONE. Also, each manufacturer or supplier product description contains essential information about this substance including clinical data, stability zones, countries where PIRFENIDONE is already registered in. Manufacturers also have special, and delivery terms.

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over these medicine offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and ordering process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers or suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are onboarded on the platform. This allows us to screen PIRFENIDONE manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.